The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medical Foods for Inborn Errors of Metabolism Market Research Report 2025

Global Medical Foods for Inborn Errors of Metabolism Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1619372

No of Pages : 96

Ask Your Query

Synopsis

Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids.

Global Medical Foods for Inborn Errors of Metabolism market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Foods for Inborn Errors of Metabolism market research.

Key manufacturers engaged in the Medical Foods for Inborn Errors of Metabolism industry include Nestlé, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA and Galen Limited, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Medical Foods for Inborn Errors of Metabolism were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medical Foods for Inborn Errors of Metabolism market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Foods for Inborn Errors of Metabolism market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Nestlé
  •     Abbott
  •     Reckitt Benckiser Group
  •     Ajinomoto
  •     Solace Nutrition
  •     Primus Pharmaceuticals
  •     BioMarin Pharmaceutical
  •     Danone SA
  •     Galen Limited
  •     PKU-MDMIL

Segment by Type

  •     Amino Acid
  •     Glytactin with GMP
  •     Amino Acid-Modified Infant Formula With Iron
  •     Low Protein Food
  •     Others

Segment by Application

  •     Phenylketonuria (PKU)
  •     Maple Syrup Urine Disease (MSUD)
  •     Urea Cycle Disorders
  •     Renal Disease
  •     Others

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Medical Foods for Inborn Errors of Metabolism report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

   1.1 Product Overview and Scope of Medical Foods for Inborn Errors of Metabolism
    1.2 Medical Foods for Inborn Errors of Metabolism Segment by Type
        1.2.1 Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Type (2023-2029)
        1.2.2 Amino Acid
        1.2.3 Glytactin with GMP
        1.2.4 Amino Acid-Modified Infant Formula With Iron
        1.2.5 Low Protein Food
        1.2.6 Others
    1.3 Medical Foods for Inborn Errors of Metabolism Segment by Application
        1.3.1 Global Medical Foods for Inborn Errors of Metabolism Market Value by Application: (2023-2029)
        1.3.2 Phenylketonuria (PKU)
        1.3.3 Maple Syrup Urine Disease (MSUD)
        1.3.4 Urea Cycle Disorders
        1.3.5 Renal Disease
        1.3.6 Others
    1.4 Global Medical Foods for Inborn Errors of Metabolism Market Size Estimates and Forecasts
        1.4.1 Global Medical Foods for Inborn Errors of Metabolism Revenue 2018-2029
        1.4.2 Global Medical Foods for Inborn Errors of Metabolism Sales 2018-2029
        1.4.3 Global Medical Foods for Inborn Errors of Metabolism Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Medical Foods for Inborn Errors of Metabolism Market Competition by Manufacturers
    2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Medical Foods for Inborn Errors of Metabolism Average Price by Manufacturers (2018-2023)
    2.4 Global Medical Foods for Inborn Errors of Metabolism Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Product Type & Application
    2.7 Medical Foods for Inborn Errors of Metabolism Market Competitive Situation and Trends
        2.7.1 Medical Foods for Inborn Errors of Metabolism Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Medical Foods for Inborn Errors of Metabolism Players Market Share by Revenue
        2.7.3 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario by Region
    3.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Medical Foods for Inborn Errors of Metabolism Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2018-2029
        3.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2018-2023
        3.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2024-2029
    3.3 Global Medical Foods for Inborn Errors of Metabolism Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018-2029
        3.3.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2018-2023
        3.3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2024-2029
    3.4 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
        3.4.1 North America Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029)
        3.4.3 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
        3.5.1 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029)
        3.5.3 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
        3.6.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029)
        3.6.3 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
        3.7.1 Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029)
        3.7.3 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
        3.8.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2029)
        4.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2018-2023)
        4.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2024-2029)
        4.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2018-2029)
    4.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2029)
        4.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2018-2023)
        4.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2024-2029)
        4.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2018-2029)
    4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2029)
        5.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2018-2023)
        5.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2024-2029)
        5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2018-2029)
    5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2029)
        5.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2018-2023)
        5.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2024-2029)
        5.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2018-2029)
    5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Nestlé
        6.1.1 Nestlé Corporation Information
        6.1.2 Nestlé Description and Business Overview
        6.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.1.5 Nestlé Recent Developments/Updates
    6.2 Abbott
        6.2.1 Abbott Corporation Information
        6.2.2 Abbott Description and Business Overview
        6.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.2.5 Abbott Recent Developments/Updates
    6.3 Reckitt Benckiser Group
        6.3.1 Reckitt Benckiser Group Corporation Information
        6.3.2 Reckitt Benckiser Group Description and Business Overview
        6.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.3.5 Reckitt Benckiser Group Recent Developments/Updates
    6.4 Ajinomoto
        6.4.1 Ajinomoto Corporation Information
        6.4.2 Ajinomoto Description and Business Overview
        6.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.4.5 Ajinomoto Recent Developments/Updates
    6.5 Solace Nutrition
        6.5.1 Solace Nutrition Corporation Information
        6.5.2 Solace Nutrition Description and Business Overview
        6.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.5.5 Solace Nutrition Recent Developments/Updates
    6.6 Primus Pharmaceuticals
        6.6.1 Primus Pharmaceuticals Corporation Information
        6.6.2 Primus Pharmaceuticals Description and Business Overview
        6.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.6.5 Primus Pharmaceuticals Recent Developments/Updates
    6.7 BioMarin Pharmaceutical
        6.6.1 BioMarin Pharmaceutical Corporation Information
        6.6.2 BioMarin Pharmaceutical Description and Business Overview
        6.6.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.7.5 BioMarin Pharmaceutical Recent Developments/Updates
    6.8 Danone SA
        6.8.1 Danone SA Corporation Information
        6.8.2 Danone SA Description and Business Overview
        6.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.8.5 Danone SA Recent Developments/Updates
    6.9 Galen Limited
        6.9.1 Galen Limited Corporation Information
        6.9.2 Galen Limited Description and Business Overview
        6.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.9.5 Galen Limited Recent Developments/Updates
    6.10 PKU-MDMIL
        6.10.1 PKU-MDMIL Corporation Information
        6.10.2 PKU-MDMIL Description and Business Overview
        6.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Portfolio
        6.10.5 PKU-MDMIL Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Medical Foods for Inborn Errors of Metabolism Industry Chain Analysis
    7.2 Medical Foods for Inborn Errors of Metabolism Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Medical Foods for Inborn Errors of Metabolism Production Mode & Process
    7.4 Medical Foods for Inborn Errors of Metabolism Sales and Marketing
        7.4.1 Medical Foods for Inborn Errors of Metabolism Sales Channels
        7.4.2 Medical Foods for Inborn Errors of Metabolism Distributors
    7.5 Medical Foods for Inborn Errors of Metabolism Customers

 8 Medical Foods for Inborn Errors of Metabolism Market Dynamics
    8.1 Medical Foods for Inborn Errors of Metabolism Industry Trends
    8.2 Medical Foods for Inborn Errors of Metabolism Market Drivers
    8.3 Medical Foods for Inborn Errors of Metabolism Market Challenges
    8.4 Medical Foods for Inborn Errors of Metabolism Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock